Travere to present new FILSPARI data at ASN Kidney Week 2026
Travere said it will present new data supporting FILSPARI (sparsentan) as a foundational treatment in IgA nephropathy and FSGS at ASN Kidney Week 2026.
Travere said it will present new data supporting FILSPARI (sparsentan) as a foundational treatment in IgA nephropathy and FSGS at ASN Kidney Week 2026.